{"id":"W2810093122","doi":"10.1007/s10637-017-0455-y","title":"Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors","year":2017,"lang":"en","type":"erratum","venue":"Investigational New Drugs","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":12,"is_retracted":false,"has_abstract":false,"ca_institutions":"Micropharma (Canada); London Health Sciences Centre; Juravinski Cancer Centre","funders":"","keywords":"Calcium channel; TRPV6; Calcium; Medicine; Phase (matter); Pharmacology; Internal medicine; Chemistry; Calcium metabolism","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001800801,0.001312681,0.001659219,0.00107133,0.001038147,0.001345842,0.001237059,0.003152714,0.02804295],"category_scores_gemma":[0.009937798,0.0005286126,0.001375639,0.0006220924,0.0006174922,0.001207976,0.0004678196,0.004929146,0.01132125],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001828192,"about_ca_system_score_gemma":0.002291602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003506474,"about_ca_topic_score_gemma":0.007954725,"domain_scores_codex":[0.9989889,0.0001732341,0.0002011699,0.00009344407,0.0004474864,0.00009570748],"domain_scores_gemma":[0.9965793,0.001137632,0.0003477869,0.0001623663,0.0014292,0.0003437208],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008227301,0.00007212119,0.0002899618,0.0003647165,0.00005946127,0.0005990843,0.000008386075,0.0001205541,0.0002253793,0.0003892602,0.97553,0.02151839],"study_design_scores_gemma":[0.001970152,0.0007877887,0.002248835,0.0006133494,0.000348308,0.002031551,0.00005769246,0.0007093182,0.001865289,0.001247552,0.9880704,0.00004976874],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.002546751,0.01769197,0.001833934,0.1451614,0.8092555,0.0004382886,0.005285232,0.0004262422,0.01736069],"genre_scores_gemma":[0.04089747,0.03780134,0.01147516,0.2916512,0.2114012,0.0007436005,0.01406923,0.001240129,0.3907206],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.02804295,"threshold_uncertainty_score":0.093813,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03240136017940257,"score_gpt":0.310777729779994,"score_spread":0.2783763696005914,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}